| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $105 | -100.0% |
| Cost of Revenue | $464 | -98.7% |
| Gross Profit | -$359 | -100.1% |
| R&D Expense | $21K | -12.6% |
| SG&A Expense | $627K | -43.0% |
| Interest Expense | $111K | — |
| Pre-tax Income | -$3.3M | +29.6% |
| Net Income | -$3.3M | +29.6% |
| EPS (Basic) | -$0.58 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $29K | -13.8% |
| Current Assets | $82K | -17.0% |
| Total Assets | $1.3M | +81.1% |
| Current Liabilities | $9.8M | +43.5% |
| Total Liabilities | $9.8M | +43.5% |
| Stockholders' Equity | -$8.5M | -39.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$572K | +26.4% |
| Financing Cash Flow | $567K | +126.3% |
| +31.0% |
| EPS (Diluted) | -$0.58 | +31.0% |